CMPK Inhibitors
CMPK inhibitors belong to a class of chemical compounds that have garnered interest in the fields of molecular biology due to modulating specific cellular processes. CMPK, or Cytidine Monophosphate Kinase, is an enzyme that plays a crucial role in nucleotide metabolism and the regulation of cellular nucleoside triphosphate (NTP) pools. This enzyme is responsible for the phosphorylation of cytidine monophosphate (CMP) to generate cytidine diphosphate (CDP), an essential step in the biosynthesis of DNA and RNA nucleotides. CMPK is primarily localized within the cellular nucleus and mitochondria, where it participates in maintaining the balance of nucleotides required for DNA replication, RNA transcription, and other nucleotide-dependent processes. CMPK inhibitors are designed to interact with the active site or binding domain of the CMPK enzyme, effectively inhibiting its function and influencing cellular processes dependent on CMPK-mediated nucleotide metabolism.
Structurally, CMPK inhibitors are engineered to selectively target the active site or binding domains of CMPK, ensuring high specificity for this particular enzyme. By inhibiting CMPK, these compounds may disrupt its role in phosphorylating cytidine monophosphate, leading to alterations in nucleotide pool composition and availability for DNA and RNA synthesis. The study of CMPK inhibitors is of significant interest to researchers as it provides insights into the regulatory mechanisms governing essential cellular functions related to nucleotide metabolism, DNA replication, and RNA transcription. This knowledge contributes to our understanding of basic cell biology and may have implications in various research areas, including cancer biology, virology, and the molecular basis of diseases associated with imbalanced nucleotide pools and aberrant nucleotide metabolism. However, further research is required to fully explore the extent of their applications and their impact on cellular physiology in the context of CMPK-mediated nucleotide metabolism.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with DNA-dependent RNA polymerase by preventing elongation, potentially reducing CMPK mRNA synthesis. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, which could lead to decreased transcription of the CMPK gene. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA polymerase II transcriptional elongation, possibly decreasing CMPK mRNA levels. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Inhibits cyclin-dependent kinases necessary for cell cycle progression and could downregulate CMPK expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Modulates transcription factors and signaling pathways, potentially leading to decreased expression of CMPK. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Shortens the tail of mRNA, potentially destabilizing mRNA and decreasing CMPK expression. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Blocks initiation of translation, which could lead to reduced protein levels, including CMPK. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits DNA topoisomerase I, leading to DNA damage and potential downregulation of CMPK. | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $265.00 | 9 | |
Inhibits several serine/threonine phosphatases, potentially altering expression of genes including CMPK. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts protein transport by blocking the exchange of protein and other molecules from the endoplasmic reticulum to the Golgi apparatus, potentially affecting CMPK levels. | ||||||